5.3 Million Revenue 1.5 Million EBITDA Medical Billing Business Deal

searcher profile

February 05, 2025

by a searcher from Syracuse University in New York, NY, USA

Singed LOI for a Medical Billing business focused on Podiatry Billing. Company has grown 10+% over the past two years, 28% EBITDA Margin with significant improvement opportunities. No customer concentration (top customer is 5% of revenue top 15 is 50% of revenue) - Return profile is 4.8x MoIC and 48.3% IRR. Please reach out if interested. Targeted close date is March 31st.
2
15
235
Replies
15
commentor profile
Reply by a professional
from Rhodes College in Austin, TX, USA
Hey ^redacted‌, if you're looking for equity investors feel free to send me an email at redacted Our team is interested in learning more about this deal. From the information provided it appears this fits our investors risk profile.
commentor profile
Reply by a lender
from Morehouse College in Birmingham, AL, USA
Hi Isaac - would love to learn more about this opportunity. We have a couple of platforms that could be of interest to you: 1) an SBIC Impact Fund and 2) a Missouri state fund. Both are looking for opportunities in MO. My email address is redacted Let have a conversation.
commentor profile
+13 more replies.
Join the discussion